skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

972 Total results for product and free and sample content found

Pink Sheet

Brexit Implications for Pharma Article Pack

22 Jun 2018

Are you prepared for Brexit and what it could mean for your business? In a few short months, the interim period will end and the UK will depart from the European Union, leaving uncertainty in its wake. How can you prepare for this unprecedented event? Informa Pharma Intelligence has prepared an article pack covering Brexit and the topics discussed at the recent Drug Information Association (DIA) Europe meeting, and it is now available to you – for free.

Topic Policy and regulation

Awareness

Primal Pictures Partners with Physitrack to Create a Unique Patient Education Solution

22 Jun 2018

London, UK, June 22, 2018 – Today, Primal Pictures, pioneer of the world’s most medically-accurate and detailed 3D models of human anatomy, and Physitrack, the market-leading patient engagement and Telehealth solution provider, announce their partnership on a unique anatomically augmented home exercise and patient education feature.

Medtech Insight

SOPHiA Buys In More Bioinformatics Know-How For Cancer Genomics

By Catherine Longworth 21 Jun 2018

In a move to accelerate adoption of its AI-driven genomics platform, SOPHiA Genetics has acquired Interactive Biosoftware, the French developer of Alamut, a clinical decision support software used in  genomic data interpretation.

Topic Company analysis Digital Health Business strategies

Pink Sheet

Sarepta Should Gain Clean Slate With CBER Review of DMD Gene Therapy

By Derrick Gingery 21 Jun 2018

Sarepta will face a US FDA staff with which it does not have a controversial history, the Center for Biologics Evaluation and Research, likely avoiding the reviewers that evaluated its Duchenne muscular dystrophy treatment Exondys 51.

Topic Diseases

Pink Sheet

UK Industry Raises Conflict of Interest Concerns Over NICE’s PRIMA Service

By Francesca Bruce 21 Jun 2018

PRIMA, the new service the National Institute for Health and Care Excellence offers to review economic models, must not be affected by confidentiality and conflict of interest issues, warns UK the pharmaceutical industry group, ABPI.

Topic Business strategies

Medtech Insight

Mock Audits: Has Ambiguity In EU Led To Unfair Advantage?

By Amanda Maxwell 21 Jun 2018

There's been confusion and conflicting opinions about notified bodies conducting mock audits on companies' documentation to prove conformity with the impending EU Medical Device and IVD Regulations. Has the lack of clarity led to different and unfair practices? Does it matter?

Topic Medtech

Scrip

ADA Meeting's Around The Corner: Five Things To Watch For

By Emily Hayes 21 Jun 2018

Among other debates at the American Diabetes Association annual meeting, clinicians will discuss the future of cardiovascular outcomes studies for diabetes drugs – whether they should maintain course or are due for an overhaul.

Topic Diabetes

Scrip

Learning From Human Cell Hijacking Masters: ENYO Pharma Takes Virus Tricks Into Drug Discovery

By Eleanor Malone 21 Jun 2018

Emerging Company Profile: ENYO Pharma has been around for barely four years, but it is already advancing its lead programs into Phase II trials in hepatitis B and NASH, and anticipates many more uses for its virology-based platform that will go way beyond treating virus infections.

Topic Company analysis Hepatitis B

Awareness

Global Generics Podcast 2018

20 Jun 2018

Listen to this podcast with Generics bulletin editor Aidan Fry and deputy editor David Wallace. The Global Generics & Biosimilars Awards reward ‘best practice’ in the two industries, while at the same time encouraging improvements in every aspect of the way business is conducted.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: